BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34559005)

  • 1. Assisted versus Manual Interpretation of Low-Dose CT Scans for Lung Cancer Screening: Impact on Lung-RADS Agreement.
    Jacobs C; Schreuder A; van Riel SJ; Scholten ET; Wittenberg R; Wille MMW; de Hoop B; Sprengers R; Mets OM; Geurts B; Prokop M; Schaefer-Prokop C; van Ginneken B
    Radiol Imaging Cancer; 2021 Sep; 3(5):e200160. PubMed ID: 34559005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observer variability for Lung-RADS categorisation of lung cancer screening CTs: impact on patient management.
    van Riel SJ; Jacobs C; Scholten ET; Wittenberg R; Winkler Wille MM; de Hoop B; Sprengers R; Mets OM; Geurts B; Prokop M; Schaefer-Prokop C; van Ginneken B
    Eur Radiol; 2019 Feb; 29(2):924-931. PubMed ID: 30066248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interobserver variability in Lung CT Screening Reporting and Data System categorisation in subsolid nodule-enriched lung cancer screening CTs.
    Yoon SH; Kim YJ; Doh K; Kim J; Lee KH; Lee KW; Kim J
    Eur Radiol; 2021 Sep; 31(9):7184-7191. PubMed ID: 33733688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Interobserver Agreement on Lung-RADS Classification of Solid Nodules Using Semiautomated CT Volumetry.
    Gierada DS; Rydzak CE; Zei M; Rhea L
    Radiology; 2020 Dec; 297(3):675-684. PubMed ID: 32930652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval.
    Silva M; Milanese G; Sestini S; Sabia F; Jacobs C; van Ginneken B; Prokop M; Schaefer-Prokop CM; Marchianò A; Sverzellati N; Pastorino U
    Eur Radiol; 2021 Apr; 31(4):1956-1968. PubMed ID: 32997182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CO-RADS: A Categorical CT Assessment Scheme for Patients Suspected of Having COVID-19-Definition and Evaluation.
    Prokop M; van Everdingen W; van Rees Vellinga T; Quarles van Ufford H; Stöger L; Beenen L; Geurts B; Gietema H; Krdzalic J; Schaefer-Prokop C; van Ginneken B; Brink M;
    Radiology; 2020 Aug; 296(2):E97-E104. PubMed ID: 32339082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung-RADS Category 4X: Does It Improve Prediction of Malignancy in Subsolid Nodules?
    Chung K; Jacobs C; Scholten ET; Goo JM; Prosch H; Sverzellati N; Ciompi F; Mets OM; Gerke PK; Prokop M; van Ginneken B; Schaefer-Prokop CM
    Radiology; 2017 Jul; 284(1):264-271. PubMed ID: 28339311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung-RADS Version 1.0 versus Lung-RADS Version 1.1: Comparison of Categories Using Nodules from the National Lung Screening Trial.
    Kastner J; Hossain R; Jeudy J; Dako F; Mehta V; Dalal S; Dharaiya E; White C
    Radiology; 2021 Jul; 300(1):199-206. PubMed ID: 33944631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiological Society of North America (RSNA) Expert Consensus Statement Related to Chest CT Findings in COVID-19 Versus CO-RADS: Comparison of Reporting System Performance Among Chest Radiologists and End-User Preference.
    O' Neill SB; Byrne D; Müller NL; Jalal S; Parker W; Nicolaou S; Bilawich AM
    Can Assoc Radiol J; 2021 Nov; 72(4):806-813. PubMed ID: 33138634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrater Reliability of NI-RADS on Posttreatment PET/Contrast-enhanced CT Scans in Head and Neck Squamous Cell Carcinoma.
    Hsu D; Rath TJ; Branstetter BF; Anzai Y; Phillips CD; Juliano AF; Mosier KM; Bazylewicz MP; Poliashenko SM; Kulzer MH; Rhyner PA; Risk B; Wiggins RH; Aiken AH
    Radiol Imaging Cancer; 2021 May; 3(3):e200131. PubMed ID: 34018845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of the Vancouver Risk Calculator Compared with Lung-RADS in an Urban, Diverse Clinical Lung Cancer Screening Cohort.
    Kessler A; Peng R; Mardakhaev E; Haramati LB; White CS
    Radiol Imaging Cancer; 2020 Mar; 2(2):e190021. PubMed ID: 33778703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Risk in Subsolid Nodules in the National Lung Screening Trial.
    Hammer MM; Palazzo LL; Kong CY; Hunsaker AR
    Radiology; 2019 Nov; 293(2):441-448. PubMed ID: 31526256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.
    Barbosa EJM; Yang R; Hershman M
    AJR Am J Roentgenol; 2021 Apr; 216(4):919-926. PubMed ID: 32755178
    [No Abstract]   [Full Text] [Related]  

  • 14. Lung Cancer CT Screening and Lung-RADS in a Tuberculosis-endemic Country: The Korean Lung Cancer Screening Project (K-LUCAS).
    Kim H; Kim HY; Goo JM; Kim Y
    Radiology; 2020 Jul; 296(1):181-188. PubMed ID: 32286195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Deep Learning-Based Denoising and Iterative Reconstruction for Ultra-Low-Dose CT of the Chest: Image Quality and Lung-RADS Evaluation.
    Hata A; Yanagawa M; Yoshida Y; Miyata T; Tsubamoto M; Honda O; Tomiyama N
    AJR Am J Roentgenol; 2020 Dec; 215(6):1321-1328. PubMed ID: 33052702
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of reader variability in the interpretation of follow-up CT scans at lung cancer screening.
    Singh S; Pinsky P; Fineberg NS; Gierada DS; Garg K; Sun Y; Nath PH
    Radiology; 2011 Apr; 259(1):263-70. PubMed ID: 21248232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.
    Pinsky PF; Gierada DS; Black W; Munden R; Nath H; Aberle D; Kazerooni E
    Ann Intern Med; 2015 Apr; 162(7):485-91. PubMed ID: 25664444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparison of the PanCan Model and Lung-RADS to Assess Cancer Probability Among People With Screening-Detected, Solid Lung Nodules.
    Sundaram V; Gould MK; Nair VS
    Chest; 2021 Mar; 159(3):1273-1282. PubMed ID: 33393476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Lung-Screening Reporting and Data System Versus Pan-Canadian Early Detection of Lung Cancer Nodule Risk Calculation in the Alberta Lung Cancer Screening Study.
    Tremblay A; Taghizadeh N; MacGregor JH; Armstrong G; Bristow MS; Guo LLQ; Lydell C; Pereira R; Lee A; Elliot T; MacEachern P; Graham A; Dickinson JA; Koetzler R; Lam SC; Yang H; Bédard EL; Tammemagi M; Burrowes P
    J Am Coll Radiol; 2019 Oct; 16(10):1425-1432. PubMed ID: 31103442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignancy estimation of Lung-RADS criteria for subsolid nodules on CT: accuracy of low and high risk spectrum when using NLST nodules.
    Chung K; Jacobs C; Scholten ET; Mets OM; Dekker I; Prokop M; van Ginneken B; Schaefer-Prokop CM
    Eur Radiol; 2017 Nov; 27(11):4672-4679. PubMed ID: 28439653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.